Description
abm | BAK Stable Knockdown HN12 Cell Line | T6416
When cells undergo death triggered by chemotherapeutic agents, the BCL-2-family-dependent mitochondrial apoptotic pathway is activated. By activating BAX and/or BAK, one of the BCL-2 subgroups, BH3-only proteins cause cytochrome to release from the mitochondria. shRNAs were introduced specific for BAK and BAX in HN12 cells so their roles can be studied. The results suggest that both BAX and BAK are required for apoptosis induced by simultaneous inhibition of BCL-2.
Biosafety:
II
Organism:
Human (H. sapiens)
Source Organ:
Other
Growth Properties:
Adherent
Morphology:
Epithelial-like
Clones:
N/A
Passage Number:
N/A
Population Doner:
24 - 36 hours
Seeding Density:
N/A
Markers:
Down-regulated BAK Vector information: shBAK: TRCN0000033466 TG GTACG AAGATTCTTC AAAT
Applications:
For Research Use Only
Doner Gender:
N/A
Donor Ethnicity:
N/A
Knockdown Method:
N/A
Induction:
N/A
Overexpression:
N/A
Freeze Thaw:
N/A
Propagation:
Preservation:
1. Freeze Medium: Complete growth medium with 20% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.
Quality Control:
1) Immunoprecipitation; 2) Western blot; 3) FACS; 4) Crystal violet assay; 5) Cell viability assays for Bliss Independence analysis
Tumorgenicn:
N/A
Shipping Conditions:
Dry Ice
Storage Contidions:
-180°C